Abstract
Cardiac fibrosis following myocardial infarction (MI) leads to heart failure due to the excessive deposition of extracellular matrix by activated myofibroblasts. This study demonstrates that mesenchymal stem cells (MSCs) preconditioned under hypoxic conditions (H-MSCs) significantly inhibit cardiac fibroblast activation. This anti-fibrotic effect is mediated by the paracrine secretion of leptin, which suppresses the TGF-β/Smad2 and MRTF-A signaling pathways.
Introduction
Following a heart attack, the cardiac environment undergoes significant remodeling. A central component of this process is the transformation of quiescent cardiac fibroblasts into contractile, collagen-secreting myofibroblasts. While MSC therapy shows promise in mitigating this damage, the low survival rate of transplanted cells in the ischemic heart remains a challenge. "Priming" MSCs with hypoxia (HPC) mimics the injured environment and enhances their therapeutic efficacy. This research identifies leptin as a key mediator in the H-MSC secretome that prevents pathological scarring.
Mechanisms of Fibroblast Inhibition
The researchers utilized a two-chamber co-culture system to isolate the effects of secreted factors. They found that H-MSCs significantly reduced the expression of alpha-smooth muscle actin (α-SMA), a hallmark of myofibroblast activation, and decreased the production of Collagen type I.
As shown in the figure above, hypoxia and TGF-β1 stimulation (common triggers in the post-MI heart) lead to a marked increase in α-SMA mRNA and protein levels (Panels A-C) and Collagen I production (Panels D-E). Crucially, these triggers also activate the TGF-β1/p-Smad2 pathway (Panels F-G), which H-MSCs are able to counteract through leptin signaling.
The Role of Leptin
To confirm the necessity of leptin, the study employed leptin-deficient (ob/ob) MSCs and leptin-receptor-deficient (db/db) fibroblasts. In these models, the anti-fibrotic benefits of H-MSCs were largely abolished. Interestingly, while systemic leptin is often associated with pro-fibrotic effects, this study suggests that local, MSC-derived leptin acts as a potent inhibitor of the MRTF-A and TGF-β/Smad2 pathways, preventing the "reprogramming" of fibroblasts into scar-forming cells.
Conclusion
Hypoxia preconditioning enhances the paracrine profile of MSCs, specifically upregulating leptin expression by over five-fold. This MSC-derived leptin serves as a critical signal to dampen the fibrotic response in the heart. These findings highlight a potential therapeutic strategy for preventing heart failure by modulating the local signaling environment post-infarction.
Summary updated